乙型肝炎病毒相关弥漫性大B细胞淋巴瘤的遗传学图谱
本研究对275例中国弥漫性大B细胞淋巴瘤(DLBCL)患者进行分析,发现合并乙型肝炎病毒(HBV)感染(HBsAg阳性)者年龄更轻、诊断时疾病分期更晚且总生存期缩短。对96例肿瘤及对应外周血样本进行全基因组/外显子组测序、对179例肿瘤进行靶向测序,发现HBsAg阳性DLBCL基因组突变率增高且突变靶点独特,部分可由APOBEC和活化诱导胞苷脱氨酶活性解释。转录组分析显示HBV相关基因表达特征由BCL6、FOXO1和ZFP36L1调控的基因富集所贡献。免疫球蛋白重链基因序列分析支持抗原非依赖机制而非慢性抗原刺激模型。
要点
- HBsAg阳性DLBCL患者年龄更轻、诊断时分期更晚且总生存期缩短。
- HBsAg阳性DLBCL基因组突变率增高,突变靶点独特,部分与APOBEC和AID活性相关。
- HBV相关表达特征由BCL6、FOXO1和ZFP36L1调控基因富集贡献,支持抗原非依赖淋巴瘤发生机制。
核心结论
- 本研究首次 comprehensive 基因组和转录组研究提示HBV感染与B细胞恶性肿瘤之间存在关联。
- 研究中鉴定的遗传学改变可能为开发新的治疗策略提供机会。
研究设计与样本
- 共纳入275例中国DLBCL患者进行特征分析。
- 对96例肿瘤及对应外周血样本进行全基因组/外显子组测序,对179例肿瘤进行靶向测序。
- 进行转录组分析及免疫球蛋白重链基因序列分析。
主要发现
- 合并HBV感染(HBsAg阳性)的DLBCL患者年龄更轻、诊断时疾病分期更晚且总生存期缩短。
- HBsAg阳性DLBCL基因组突变率增高,突变靶点独特,部分可由APOBEC和活化诱导胞苷脱氨酶活性解释。
- HBV相关基因表达特征由BCL6、FOXO1和ZFP36L1调控的基因富集所贡献。
- 免疫球蛋白重链基因序列分析支持抗原非依赖机制而非慢性抗原刺激模型参与HBV相关淋巴瘤发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B virus (HBV) infection is endemic in some parts of Asia, Africa, and South America and remains to be a significant public health problem in these areas. It is known as a leading risk factor for the development of hepatocellular carcinoma, but epidemiological studies have also shown that the infection may increase the incidence of several types of B-cell lymphoma. Here, by characterizing altogether 275 Chinese diffuse large B-cell lymphoma (DLBCL) patients, we showed that patients with concomitant HBV infection (surface antigen positive [HBsAg+]) are characterized by a younger age, a more advanced disease stage at diagnosis, and reduced overall survival. Furthermore, by whole-genome/exome sequencing of 96 tumors and the respective peripheral blood samples and targeted sequencing of 179 tumors from these patients, we observed an enhanced rate of mutagenesis and a distinct set of mutation targets in HBsAg+ DLBCL genomes, which could be partially explained by the activities of APOBEC and activation-induced cytidine deaminase. By transcriptome analysis, we further showed that the HBV-associated gene expression signature is contributed by the enrichment of genes regulated by BCL6, FOXO1, and ZFP36L1. Finally, by analysis of immunoglobulin heavy chain gene sequences, we showed that an antigen-independent mechanism, rather than a chronic antigenic simulation model, is favored in HBV-related lymphomagenesis. Taken together, we present the first comprehensive genomic and transcriptomic study that suggests a link between HBV infection and B-cell malignancy. The genetic alterations identified in this study may also provide opportunities for development of novel therapeutic strategies.
引用
- Ren W, Ye X, Su H, et al. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018. PMID: 29545328. doi:10.1182/blood-2017-11-817601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。